Senate Files

Bills

S. 2658 119th Congress

Medication Affordability and Patent Integrity Act

Latest action, Jul 28, 2026: Placed on Senate Legislative Calendar under General Orders. Calendar No. 528.

How the Senate voted

The Senate hasn't taken a roll call on this bill in the Congresses covered.

1 cosponsor

Sponsored by Margaret Wood Hassan (Democrat). Cosponsors by party, House members included:

  • Democrats
  • Republicans
  • Independents
Cosponsors
0 D · 1 R
  • Democrat
  • Republican
  • Independent
1 senators cosponsoring

Referred to: Senate: Health, Education, Labor, and Pensions Committee

Who lobbied on it

Clients whose quarterly lobbying reports named it, each quarter.

37 clientsQ3 2025Q3 2026

The clients with the most reports naming it. A report's amount covers all of that client's lobbying in the quarter, not just this bill.

BCBSM INC
5 reports
BIOTECHNOLOGY INNOVATION ORGANIZATION
5 reports
FRESENIUS KABI
S-3 GROUP
5 reports
GSK (FKA GLAXOSMITHKLINE INC.)
5 reports
JOHNSON & JOHNSON SERVICES INC
5 reports
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
5 reports
VIATRIS INC
5 reports
BLUE CROSS AND BLUE SHIELD ASSOCIATION
4 reports
BLUE CROSS AND BLUE SHIELD OF FLORIDA INC
4 reports
CAMPAIGN FOR SUSTAINABLE DRUG PRICING (CSRXP)
WHITMER & WORRALL, LLC
4 reports
GUIDEWELL MUTUAL HOLDING CORPORATION
4 reports
AMGEN INC
3 reports
ASSOCIATION FOR ACCESSIBLE MEDICINES
3 reports
FRESENIUS KABI USA LLC
3 reports
PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC
COVINGTON & BURLING LLP
3 reports
All 25 of 42 clients
ClientLobbying firmReportsReports totalingFromToSenate
BCBSM INC5$148KQ4 2025Q3 2026yes
BIOTECHNOLOGY INNOVATION ORGANIZATION5$9.4MQ4 2025Q3 2026yes
FRESENIUS KABIS-3 GROUP5$0Q4 2025Q3 2026yes
GSK (FKA GLAXOSMITHKLINE INC.)5$6.6MQ4 2025Q3 2026yes
JOHNSON & JOHNSON SERVICES INC5$11.2MQ4 2025Q3 2026yes
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA5$44.0MQ4 2025Q3 2026yes
VIATRIS INC5$2.4MQ4 2025Q3 2026yes
BLUE CROSS AND BLUE SHIELD ASSOCIATION4$5.1MQ4 2025Q2 2026yes
BLUE CROSS AND BLUE SHIELD OF FLORIDA INC4$380KQ4 2025Q2 2026yes
CAMPAIGN FOR SUSTAINABLE DRUG PRICING (CSRXP)WHITMER & WORRALL, LLC4$200KQ4 2025Q2 2026yes
GUIDEWELL MUTUAL HOLDING CORPORATION4$30KQ4 2025Q2 2026yes
AMGEN INC3$8.2MQ1 2026Q3 2026yes
ASSOCIATION FOR ACCESSIBLE MEDICINES3$2.5MQ1 2026Q3 2026yes
FRESENIUS KABI USA LLC3$1.6MQ3 2025Q3 2026yes
PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INCCOVINGTON & BURLING LLP3$0Q3 2025Q3 2026yes
AMERICA'S HEALTH INSURANCE PLANS INC (AHIP)2$6.0MQ2 2026Q3 2026yes
AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS2$510KQ2 2026Q3 2026yes
AMGENTHE NICKLES GROUP, LLC2$0Q2 2026Q3 2026yes
ASSOCIATION OF ACCESSIBLE MEDICINES (FORMERLY KNOWN AS GPHA)FIERCE GOVERNMENT RELATIONS2$120KQ2 2026Q3 2026yes
BLOOD CANCER UNITED (FKA THE LEUKEMIA & LYMPHOMA SOCIETY)2$710KQ2 2026Q3 2026yes
BLUE CROSS AND BLUE SHIELD OF KANSAS INC2$20KQ1 2026Q2 2026yes
CHAMBER OF COMMERCE OF THE U.S.A.2$33.4MQ2 2026Q3 2026yes
COUNCIL FOR INNOVATION PROMOTION (C4IP)RADIUS ADVOCACY, LLC2$0Q2 2026Q3 2026yes
EISAI INC.2$1.2MQ2 2026Q3 2026yes
PHARMACEUTICAL INDUSTRY LABOR MANAGEMENT ASSOCIATIONTIBER CREEK GROUP2$100KQ2 2026Q3 2026yes